Green Fluorescent Protein as a Selectable Marker of Fibronectin-Facilitated Retroviral Gene Transfer in Primary Human T Lymphocytes
Authors:
- Nelly NorazNNNelly Noraz
- Myriam BoyerMBMyriam Boyer
- Arjen Q. BakkerABArjen Q. Bakker
- Karen PollokKPKaren Pollok
- Cosette RebouissouCRCosette Rebouissou
- Ergen SpitsESErgen Spits
- Naomi TaylorNTNaomi Taylor
- 1 January 1999
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 10 (1) , 5-14
Abstract
The success of gene therapy strategies for congenital and acquired blood disorders requires high levels of gene transfer into hematopoietic cells. Retroviral vectors have been extensively used to deliver foreign genes to mammalian cells and improvement of transduction protocols remains dependent on markers that can be rapidly monitored and used for efficient selection of transduced cells. The enhanced green fluorescent protein (EGFP) is a suitable reporter molecule for gene expression because of its lack of cytotoxicity and stable fluorescence signal that can be readily detected by flow cytometry. However, attempts to adapt the GFP system to stable transduction of human lymphocytes have not been satisfactory. In this article, transductions of primary human T lymphocytes were performed using cell-free supernatants from a PG13 packaging cell line in which a retroviral vector expressing EGFP was pseudotyped with the gibbon ape leukemia virus (GALV) envelope. Using this system combined with a fibronectin-facilitated protocol, primary lymphocytes were transduced with a mean gene transfer efficiency of 27.5% following a 2-day stimulation with either PHA or anti- CD3/CD28 antibodies. Conditions that increased the entry of lymphocytes into cell cycle did not consistently correlate with enhanced gene transfer, indicating that factors other than proliferation are important for op- timal retroviral gene transfer. These results demonstrate the utility of EGFP as a marker for human T cell transduction and will enable further optimization of T cell gene therapy protocols.Keywords
This publication has 39 references indexed in Scilit:
- Enhanced Green Fluorescent Protein as an Efficient Reporter Gene for Retroviral Transduction of Human Multipotent Lymphoid PrecursorsHuman Gene Therapy, 1998
- Fibronectin Fragment-Facilitated Retroviral Transfer of the Glutathione-S-Transferase π Gene into CD34 + Cells to Protect Them Against Alkylating AgentsHuman Gene Therapy, 1997
- Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a markerGene Therapy, 1997
- Green Fluorescent Protein Retroviral Vectors: Low Titer and High Recombination Frequency Suggest a Selective DisadvantageHuman Gene Therapy, 1997
- An Enhanced Green Fluorescent Protein Allows Sensitive Detection of Gene Transfer in Mammalian CellsBiochemical and Biophysical Research Communications, 1996
- Improved Gene Transfer into Human Lymphocytes Using Retroviruses with the Gibbon Ape Leukemia Virus EnvelopeHuman Gene Therapy, 1996
- FACS-optimized mutants of the green fluorescent protein (GFP)Gene, 1996
- Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors.Journal of Clinical Investigation, 1994
- Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion.Journal of Experimental Medicine, 1992
- Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursorsNature, 1985